ILife Consulting

About the deal

London, United Kingdom – 22^nd May 2025 – Comac Medical Group (“Group”), based in the UK and backed by EdgeCap Partners, announced today the acquisition ofILIFE Consulting (“ILIFE”), a specialized Contract Research Organization (CRO) headquartered in Paris, France, renowned for its expertise in oncology, rare diseases, and complex biotech clinical trials.

The transaction represents a significant milestone for the Group on its journey to becoming the leading pan-European full-service CRO partner for small and medium-sized biopharma companies, and complements recent expansions into the United States, Germany, and the United Kingdom.

“Working with the Agile Capital Markets team was an invaluable experience. Their expertise, commitment, and strong relationships across the industry made all the difference. We could not have achieved this outcome without them, and I’m truly grateful for their support and dedication.”